Therapeutic compounds

Details Therapeutic compounds Therapeutic compounds

2007-04-16

2009-11-10

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S394000

Reexamination Certificate

active

07615642

ABSTRACT:
Compounds of formula I or pharmaceutically acceptable salts thereof:wherein R1, R2, R3and R4are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

REFERENCES:
patent: 5482956 (1996-01-01), Lunkenheimer et al.
patent: 6166219 (2000-12-01), Yamasaki et al.
patent: 6348032 (2002-02-01), Sperl et al.
patent: 6352985 (2002-03-01), Yamasaki et al.
patent: 6376515 (2002-04-01), Zhu et al.
patent: 6534535 (2003-03-01), Zhu et al.
patent: 6632815 (2003-10-01), Zhu et al.
patent: 6686368 (2004-02-01), Zhu et al.
patent: 6720317 (2004-04-01), Zhu et al.
patent: 6835739 (2004-12-01), Zhu et al.
patent: 6844367 (2005-01-01), Zhu et al.
patent: 7030139 (2006-04-01), Cheng et al.
patent: 7115645 (2006-10-01), Halfbrodt et al.
patent: 2002/0082280 (2002-06-01), Sperl et al.
patent: 2006/0052421 (2006-03-01), Welter et al.
patent: 2006/0094750 (2006-05-01), Kon-I et al.
patent: 2006/0264490 (2006-11-01), Page et al.
patent: 2007/0072853 (2007-03-01), Liu et al.
patent: 2007/0082899 (2007-04-01), Page et al.
patent: 2007/0225346 (2007-09-01), Bohlin et al.
patent: 0597304 (2001-01-01), None
patent: 0583665 (2003-03-01), None
patent: 1403255 (2004-03-01), None
patent: 5354 (1967-09-01), None
patent: 1604908 (1972-06-01), None
patent: 9411349 (1994-05-01), None
patent: 9411350 (1994-05-01), None
patent: 9724334 (1997-07-01), None
patent: 0112600 (2001-02-01), None
patent: 0119798 (2001-03-01), None
patent: 0151473 (2001-07-01), None
patent: 0200651 (2002-01-01), None
patent: 02046168 (2002-06-01), None
patent: 02085866 (2002-10-01), None
patent: 2004085385 (2004-10-01), None
patent: 2004108688 (2004-12-01), None
patent: 2004108712 (2004-12-01), None
patent: 2005007625 (2005-01-01), None
patent: 2005021547 (2005-03-01), None
patent: 2005030732 (2005-04-01), None
patent: 2005030733 (2005-04-01), None
patent: 2005030761 (2005-04-01), None
patent: 2005030762 (2005-04-01), None
patent: 2005113542 (2005-12-01), None
patent: 2006009876 (2006-01-01), None
patent: 2006012642 (2006-02-01), None
patent: 2006033627 (2006-03-01), None
patent: 2006033628 (2006-03-01), None
patent: WO 2006/033629 (2006-03-01), None
patent: WO 2006/033630 (2006-03-01), None
patent: WO 2006/033631 (2006-03-01), None
patent: WO 2006/033632 (2006-03-01), None
patent: WO 2006/033633 (2006-03-01), None
patent: WO 2006/048754 (2006-05-01), None
patent: WO 2006/078941 (2006-07-01), None
patent: WO 2007/108754 (2007-09-01), None
Final Rejection issued for U.S. Appl. No. 11/419,603, filed Dec. 24, 2008.
Final Rejection issued for U.S. Appl. No. 11/689,864 filed Jan. 8, 2009.
Chawla et al “Challenges in Polymorphism of Pharmaceuticals,” CRIPS, vol. 5(1), Jan.-Mar. 2004, pp. 9-12.
Newman et al., “Solid-state analysis of the active pharmaceutical ingredient in drug products,” Drug Discovery Today, vol. 8(19), Oct. 2003, pp. 898-905.
Non-Final Office Action issued for U.S. Appl. No. 11/419,603 filed Jun. 23, 2008.
Non-Final Office Action issued for U.S. Appl. No. 11/689,864 filed Jul. 9, 2008.
Brittain et al., “Effects of Pharmaceutical Processing on Drug Polymorphs and Solvates,” Polymorphism in Pharmaceutical Solids, vol. 95, pp. 331-361 , Drug and the Pharmaceutical Science, 1999.
Express-Pharma-Online (http://www.expresspharmaonline.com/20031023/edit02.shtml) Express Pharma Pulse, issued Oct. 23, 2003.
Evans et al., “Synthesis of a group of 1H-benzimidazoles and their screening for antiinflammatory activity,” Eur J Med Chem, 1996, vol. 31, pp. 635-642, example 27.
Holenz et al., “Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands,” J. Med. Chem., 2005, vol. 48, pp. 1781-1795, table 1, compound 16, abstract.
Li et al., “Benzimidazole derivatives as novel nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists. Part 2: Benzimidazole-5-sulfonamides,” Bioorganic & Medicinal Chemistry Letters, 2005, 15(3), pp. 805-807.
STN International, File Caplus, accession No. 1972:419030, doc. No. 77:19030, Koshienko et al., “Benzo(1,2-d:3,4-d')diimidazole derivatives. II. Behavior of 3,6-dimethyl-and 3,6,7-trimethylbenzo(1,2-d:3,4-d')diimidazole toward nucleophilic agents,” Khimiya Geterotsiklicheskikh Soedinenii, 1971, 7(8), pp. 1132-5; XP002307925.
STN Intnl, File Chemcats, access No. 2003:1839419, Benzenesulfonamide, N-(1,2-dimethy1-1H-benzimidazol-5-y1)-, CAS Reg No. 488708-12-9; & STN Intnl, File Chemcats, access No. 2003:2399372, “Benzenesulfonamide, N-(2-methyl-1-(phenylmethyl)-1H-benzimidazol-5-yl-”, CAS Registry No. 488841-64-1; & STN Intnl, File Chemcats, access No. 2003:2595844, “Benzenesulfonamide, 4-methyl-N-(2-methyl-1-(phenyImethyl)-1H-benzimidazole-5-yl)-”, CAS Reg No. 312617-94-0.
STN Intnl, File Chemcats, accession No. 2003:1839419, “Benzenesulfonamide, N-(1,2-dimethyl-1H-benzimidazol-5-yl)-” CAS Registry No. 488708-12-9; & STN Intnl, File Chemcats, accession No. 2003:1845322, “Benzenesulfonamide, 4-bromo-N-(1,2-dimethyl-1H-benzimidazol-5-yl)-”, CAS Registry No. 489397-82-2; & STN Intnl. File Chemcats, accession No. 2003:2305521, “Benzenesulfonamide, N-(1,2-dimethyl-1H-benzinnidazol-5-yl)-1- fluoro-”, CAS Registry No. 503429-33-2.
STN Intnl, file Registry, see RN: 848855-83-4, Apr. 20, 2005.
STN Intnl, File Caplus, accession No. 1975:408737, doc No. 83:8737, Bieksa, V. et al., “Relation of the reactivity of chloroethyl derivatives of 3,4-diaminobenzenesulfopiperidides to the structure of alkylating group”, Lietuvos TSR Mokslu Akademijos Darbai, Serija B: Chemija, Technika, Fizine Geografija, (1974), (3) 91-8.
STN Intnl, File Caplus, accession No. 1973:515496, doc No. 79:115496, Bieksa, V. et al. “Chloroalkyl derivatives of benzimidazoles. 1. Chloroethyl derivatives of 2-methylbenzimidazole-5-sulfonamide,” Lietuvos TSR Mokslu Akademijos Darbai, Serija B: Chemija, Technika, Fizine Geografija, (1973), (2), 93-103.
ISR issued for PCT/SE2007/000359 on Aug. 8, 2007.
English abstract for EP 0597304, 1994.
English abstract for EP 1604908, 1973.
English abstract for FR 5354M, 1996.
English abstract for WO 9411349, 1994.
English abstract for WO 9411350, 1994.
English abstract for WO 9724334, 1997.
English abstract for WO 0151473, 2001.

Affiliated with

Also associated with

Rating

Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4119251